NEW YORK, Jan. 10 (GenomeWeb News) - Invitrogen said today that the US Department of Defense has awarded its Federal Systems subsidiary $970,000 to develop protein microarrays for biothreat agents.
The work is designed to support the US Army Medical Research and Material Command, Invitrogen said. The research will be conducted under the direction of James Meegan, senior director of research and development at Invitrogen; and Robert Ulrich of the US Army Medical Research Institute of Infectious Diseases.
Invitrogen's ProtoArray protein microarrays consist of complete sets of pure, functional proteins from specific organisms spotted onto glass slides in a high density configuration. Invitrogen developed them in 2001 as a means to enhance the detection and analysis of biomolecular interactions. They are sold using protein sets derived from both the yeast and human genomes.